title: Hydroxychloroquine for chronic myeloid leukemia: complete cure on the horizon?
authors.forename: Arunima
authors.initials: A
authors.lastname: Mukhopadhyay
authors.forename: Gudmundur V
authors.initials: GV
authors.lastname: Helgason
authors.forename: Maria
authors.initials: M
authors.lastname: Karvela
authors.forename: Tessa L
authors.initials: TL
authors.lastname: Holyoake
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001549:Benzamides; D017322:Clinical Trials, Phase II as Topic; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000627:therapeutic use*; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008297:Male; D010879:Piperazines / Q000008:administration & dosage; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D011743:Pyrimidines / Q000008:administration & dosage; D016032:Randomized Controlled Trials as Topic
chemical_list: D001549:Benzamides; D010879:Piperazines; D047428:Protein Kinase Inhibitors; D011743:Pyrimidines; D006886:Hydroxychloroquine; D000068877:Imatinib Mesylate